MARKED INCREASE IN PLASMA HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AFTER PROLONGED FASTING DURING RAMADAN

被引:91
作者
MAISLOS, M
KHAMAYSI, N
ASSALI, A
ABOURABIAH, Y
ZVILI, I
SHANY, S
机构
[1] Soroka Medical Center of Kupat Holim, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva
关键词
RAMADAN; FASTING; CHOLESTEROL; LIPOPROTEINS; HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL; GORGING; NIBBLING;
D O I
10.1093/ajcn/57.5.640
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
We evaluated the effect of the Ramadan fasting on plasma lipids and lipoproteins in normal individuals. Twenty-four healthy subjects were studied before the end of the Ramadan month (Ram) and for 1 mo thereafter. Plasma total cholesterol (TC), triglycerides, low-density-lipoprotein cholesterol (LDL-C), and very-low-density-lipoprotein cholesterol (VLDL-C) did not change. High-density-lipoprotein cholesterol (HDL-C) was 30% higher (P < 0.005) at the end of Ram; apolipoprotein A-I also increased (P < 0.0001), Both the ratios of TC to HDL-C and LDL-C to HDL-C (P < 0.001) decreased at Ram. There was a striking nonpharmacologic improvement in plasma HDL-C and ratios of TC to HDL-C and LDL-C to HDL-C, which were most probably induced by eating one large evening meal a day. Further studies to determine the mechanism of this observation are underway.
引用
收藏
页码:640 / 642
页数:3
相关论文
共 23 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   EFFECT OF WEIGHT RESTORATION ON THE DYSLIPOPROTEINEMIA OF ANOREXIA-NERVOSA [J].
ARDEN, MR ;
WEISELBERG, EC ;
NUSSBAUM, MP ;
SHENKER, IR ;
JACOBSON, MS .
JOURNAL OF ADOLESCENT HEALTH, 1990, 11 (03) :199-202
[3]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[4]   CHANGES IN CERTAIN BLOOD-CONSTITUENTS DURING RAMADAN [J].
FEDAIL, SS ;
MURPHY, D ;
SALIH, SY ;
BOLTON, CH ;
HARVEY, RF .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1982, 36 (02) :350-353
[5]  
FOSSATI P, 1982, CLIN CHEM, V28, P2077
[6]   THE PREVALENCE OF CARDIOVASCULAR RISK-FACTORS AMONG MALE BEDOUINS - A POPULATION IN TRANSITION [J].
FRASER, D ;
WEITZMAN, S ;
BLONDHEIM, S ;
SHANY, S ;
ABOURBIAH, Y .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1990, 6 (03) :273-278
[7]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[8]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9]  
FROST G, 1987, HUM NUTR-APPL NUTR, V41A, P47
[10]  
GROEN JJ, 1964, AM J CLIN NUTR, V14, P37, DOI 10.1093/ajcn/14.1.37